News
NEWARK, CA / ACCESS Newswire / April 16, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company"), a ...
Scilex (SCLX) announced that FDA has approved the company’s request for the orphan drug designation for colchicine for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback